JP2022515067A5 - - Google Patents

Info

Publication number
JP2022515067A5
JP2022515067A5 JP2021534753A JP2021534753A JP2022515067A5 JP 2022515067 A5 JP2022515067 A5 JP 2022515067A5 JP 2021534753 A JP2021534753 A JP 2021534753A JP 2021534753 A JP2021534753 A JP 2021534753A JP 2022515067 A5 JP2022515067 A5 JP 2022515067A5
Authority
JP
Japan
Prior art keywords
methylcellulose
anhydroglucose
anhydroglucose unit
hydroxyl groups
methyl groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021534753A
Other languages
English (en)
Japanese (ja)
Other versions
JP7535519B2 (ja
JP2022515067A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/066704 external-priority patent/WO2020131780A1/en
Publication of JP2022515067A publication Critical patent/JP2022515067A/ja
Publication of JP2022515067A5 publication Critical patent/JP2022515067A5/ja
Application granted granted Critical
Publication of JP7535519B2 publication Critical patent/JP7535519B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021534753A 2018-12-18 2019-12-17 メチルセルロースを含む徐放性組成物 Active JP7535519B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18213440 2018-12-18
EP18213440.3 2018-12-18
PCT/US2019/066704 WO2020131780A1 (en) 2018-12-18 2019-12-17 A sustained release composition comprising a methylcellulose

Publications (3)

Publication Number Publication Date
JP2022515067A JP2022515067A (ja) 2022-02-17
JP2022515067A5 true JP2022515067A5 (enExample) 2024-04-16
JP7535519B2 JP7535519B2 (ja) 2024-08-16

Family

ID=64744643

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021534753A Active JP7535519B2 (ja) 2018-12-18 2019-12-17 メチルセルロースを含む徐放性組成物

Country Status (4)

Country Link
US (2) US20220031623A1 (enExample)
EP (1) EP3897729B8 (enExample)
JP (1) JP7535519B2 (enExample)
WO (1) WO2020131780A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025525831A (ja) 2022-08-02 2025-08-07 ニュートリション アンド バイオサイエンシズ ユーエスエー １，リミティド ライアビリティ カンパニー アルギネートをベースとする放出調節組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2917104A1 (de) 1979-04-27 1980-11-06 Hoechst Ag Verfahren zur viskositaetserniedrigung von celluloseethern durch ozon und seine verwendung
JPS6225101A (ja) 1985-07-24 1987-02-03 Shin Etsu Chem Co Ltd 低重合度セルロ−スエ−テルの製造方法
US4734285A (en) 1985-10-28 1988-03-29 The Dow Chemical Company Sustained release compositions
US6261218B1 (en) 1998-12-01 2001-07-17 The Dow Chemical Company Process and apparatus for making low molecular weight cellulose ethers
EP1171471B2 (en) * 1999-04-01 2009-07-08 Dow Global Technologies Inc. Enhanced gel strength methylcellulose
BR0211317A (pt) * 2001-07-04 2004-12-14 Sun Pharmaceutical Ind Ltd Sistema para a liberação controlada de uma droga por meio de retenção gástrica
DE10141680B4 (de) 2001-08-25 2004-02-26 Clariant Gmbh Verfahren zur Herstellung niederviskoser Celluloseether durch sauer-oxidativen Abbau von gemahlenen und getrockneten Celluloseethern
BR112014008692B1 (pt) * 2011-10-19 2022-01-18 Nutrition & Biosciences Usa 1, Llc Medicamento fluível ou ingerível por colher, alimento, ingrediente alimentício ou suplemento alimentar
IN2014CN02795A (enExample) * 2011-10-19 2015-07-03 Dow Global Technologies Llc
BR112015019575A2 (pt) 2013-04-12 2017-07-18 Dow Global Technologies Llc polissacarídeo solúvel em água livre de amido, alimento, ingrediente de alimento, ou suplemento alimentício e método para melhorar a palatabilidade de um polissacarídeo solúvel em água livre de amido
KR20140133724A (ko) 2013-05-10 2014-11-20 한양대학교 산학협력단 저분자 메틸셀룰로오스 기반의 비경구 약물 전달 시스템
CN105358178B (zh) * 2013-07-17 2019-05-31 陶氏环球技术有限责任公司 用于施加到粘膜的包含甲基纤维素的组合物
US20160317388A1 (en) * 2014-05-01 2016-11-03 Sun Pharmaceutical Industries Limited Dual-chamber pack for extended release suspension compositions
MA41124A (fr) * 2014-12-05 2017-10-10 Sun Pharmaceutical Ind Ltd Compositions en suspension à libération prolongée à rétention gastrique
EP3216807B2 (en) 2016-03-09 2022-05-18 Shin-Etsu Chemical Co., Ltd. Coating composition containing methyl cellulose, method for producing the same, and solid preparation

Similar Documents

Publication Publication Date Title
AU2014363599B2 (en) Orally disintegrating solid dosage unit containing an estetrol component
KR102072371B1 (ko) 7-[4-(4-벤조[ｂ]티오펜-4-일-피페라진-1-일)부톡시]-1Ｈ-퀴놀린-2-온 또는 그 염을 함유하는 정제
JP7444775B2 (ja) 活性薬を高装薬した経口薄フィルム剤
BRPI0715853A2 (pt) uso de poliàis para obter formas polimorfas estÁveis de rifaximina
JP2014237658A5 (enExample)
TWI700100B (zh) 用於口服投藥之包含依澤替米貝（ｅｚｅｔｉｍｉｂｅ）及羅舒伐他汀（ｒｏｓｕｖａｓｔａｔｉｎ）的複合調配物及其製備方法
JP2019505525A (ja) Ｊａｋキナーゼ阻害剤またはその薬剤的に許容される塩を含有する医薬組成物
MX2012013090A (es) Formulaciones farmaceuticas que comprenden derivados de 1-(beta-d-glucopiranosil)-2-tienil-metilbenceno como inhibidores de transportadores de glucosa dependientes de sodio.
JP2017061576A (ja) 固形組成物
JP7104039B2 (ja) 医薬組成物
RU2008147216A (ru) Жидкая лекарственная композиция
WO2019004447A1 (ja) 医薬組成物
JP2019085364A5 (enExample)
JP2025123520A (ja) ニロチニブ錠剤
EP2723322B1 (en) Imatinib mesylate oral pharmaceutical composition and process for preparation thereof
JP2022515068A5 (enExample)
JP6453858B2 (ja) 共結晶形態でアゴメラチンを含むアゴメラチン製剤
JP2011012018A (ja) 崩壊遅延が抑制されたパロキセチン塩酸塩水和物の経口投与用医薬組成物
JP2017002022A (ja) ボリコナゾール含有製剤
EA010911B1 (ru) Ингибиторы проникновения вируса вич
CN101422441B (zh) 尼美舒利缓释片及其制备方法
JP7355846B2 (ja) 固形製剤
CZ300047B6 (cs) Farmaceutická kompozice s obsahem úcinné látky atorvastatinu
JP2025517683A5 (enExample)
EP1713452A2 (en) Sustained release pharmaceutical composition of indapamide